Japanese Journal of Cancer and Chemotherapy最新文献

筛选
英文 中文
[Pathological Complete Response after Combined Chemotherapy of Durvalumab, Gemcitabine and Cisplatin for Intrahepatic Cholangiocarcinoma-A Case Report]. 【杜伐单抗、吉西他滨、顺铂联合化疗治疗肝内胆管癌后病理完全缓解a例报告】。
Tomoki Hata, Akinobu Yasuyama, Takeo Hara, Miho Okano, Osamu Takayama, Yongkook Kim, Junichi Hasegawa, Haruhiko Imamoto
{"title":"[Pathological Complete Response after Combined Chemotherapy of Durvalumab, Gemcitabine and Cisplatin for Intrahepatic Cholangiocarcinoma-A Case Report].","authors":"Tomoki Hata, Akinobu Yasuyama, Takeo Hara, Miho Okano, Osamu Takayama, Yongkook Kim, Junichi Hasegawa, Haruhiko Imamoto","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The patient was a 66-year-old man. He came to our hospital because of abdominal discomfort. A CT scan revealed hypovascular tumors of about 70 mm in the S4/5 and 16 mm in the S6 of the liver. The S4/5 tumor was directly invasive into the greater omentum and abdominal wall, and a nodule suspected of peritoneal dissemination was observed around the tumor. Based on tumor biopsy results, a diagnosis of intrahepatic cholangiocarcinoma(ICC), cT3N0M1, Stage ⅣB was made. A total of 9 courses of GCD therapy(gemcitabine+cisplatin+durvalumab)were performed for ICC and the tumor was found to have shrunk, and the S6 tumor was obscured. The FDG-PET/CT scan also showed similar results, and the patient was judged to be curative, and surgery was performed 8 months after the initial diagnosis. Laparoscopic hepatic S4a/5 subsegmentectomy and S6 partial hepatectomy were performed. Intraoperative findings showed no peritoneal dissemination, and cytology of washed ascites was negative. Histopathological examination did not reveal any tumor cells, and the patient was judged to have a pathological complete response(pCR). There are few reports of ICC with pCR after GCD therapy, and we report this case here with a review of the literature.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"52 2","pages":"167-169"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143617452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A Case of Successful Hepatic Resection of Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab for Recurrent Liver and Lung Metastases]. [阿特唑单抗联合贝伐单抗治疗复发性肝、肺转移瘤肝切除成功1例]。
Kenta Shiraishi, Daisuke Suzuki, Koya Fujii, Tsukasa Takayashiki, Shigetsugu Takano, Nozomu Sakai, Isamu Hosokawa, Takashi Mishima, Takanori Konishi, Hitoe Nishino, Kensuke Suzuki, Shinichiro Nakada, Masayuki Ohtsuka
{"title":"[A Case of Successful Hepatic Resection of Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab for Recurrent Liver and Lung Metastases].","authors":"Kenta Shiraishi, Daisuke Suzuki, Koya Fujii, Tsukasa Takayashiki, Shigetsugu Takano, Nozomu Sakai, Isamu Hosokawa, Takashi Mishima, Takanori Konishi, Hitoe Nishino, Kensuke Suzuki, Shinichiro Nakada, Masayuki Ohtsuka","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Drug therapy for hepatocellular carcinoma has made remarkable progress in recent years, and surgical resection of tumors that respond well to drug therapy has been performed in some cases. We report a case of hepatocellular carcinoma with hepatopulmonary metastases that was successfully treated with atezolizumab plus bevacizumab and surgically resected. The patient was a 56-year-old man who underwent a posterior segmentectomy and was diagnosed with hepatocellular carcinoma. Three months after the surgery, CT revealed multiple liver and lung metastases. Fifteen courses of atezolizumab and bevacizumab were administered. Drug therapy was effective, and most metastases disappeared; however, the liver metastasis remained in segment 8/4, and partial resection of the liver was performed. Recurrence was observed in liver segment 2 after 1 year and 2 months, and partial resection of the liver was performed. The patient is currently alive and recurrence-free 3 months after the surgery. With progress in drug therapy, multimodal treatment for unresectable hepatocellular carcinoma is expected to improve the prognosis.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"52 2","pages":"173-175"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143617432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[From the Perspective of a Geriatrician]. [从老年医学专家的角度来看]。
Ken Sugimoto
{"title":"[From the Perspective of a Geriatrician].","authors":"Ken Sugimoto","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Previous research has revealed that in older patients undergoing cancer treatment, including chemotherapy and surgery, physical or mental/psychological impairment and social background, in addition to clinical condition or organ damage, can affect not only the prognosis but also the health life expectancy. Therefore, in addition to conventional pre-treatment or pre-operative evaluations, geriatric evaluation, such as comprehensive geriatric assessment(CGA)/geriatric assessment (GA)or physical function assessment, i.e., are required to clarify problems specific to older adults and predict their impact on postoperative complications, survival rate, quality of life(QOL), etc. In particular, when a patient is judged to be'frailty', geriatric intervention based on the results of CGA/GA and physical function assessment may improve treatment or postoperative prognosis and QOL, however, the evidence related to this issue is poor, so future investigations are needed. Although the concept of'frailty'differs between the fields of geriatrics and geriatric oncology, they share the common point of not judging older patients undergoing cancer treatment or surgery based solely on their age or appearance but extracting a group in which the disadvantages of treatment or surgery outweigh the benefits. In order to conduct geriatric assessments before cancer treatment or surgery and to make interventions based on the routine assessments, multidisciplinary collaboration conducted by doctors who specialize in geriatrics is essential, so establishing such collaboration would be an urgent task.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"52 2","pages":"108-114"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143617450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Asymptomatic Hairy Cell Leukemia with Multifocal Spinal Involvement. 无症状毛细胞白血病伴多灶性脊柱受累1例。
Yasunobu Sekiguchi, Hiroki Tsutsumi, Masahisa Kudo, Yoshie Iizaki, Nobuo Maseki, Machiko Kawamura, Kazuhiko Kobayashi, Daisuke Takei, Tomoya Abe, Makoto Hanai, Toshiaki Nakayama, Yu Nishimura, Yasumasa Shimano, Kengo Takeuchi, Reimi Asaka, Satoko Baba
{"title":"A Case of Asymptomatic Hairy Cell Leukemia with Multifocal Spinal Involvement.","authors":"Yasunobu Sekiguchi, Hiroki Tsutsumi, Masahisa Kudo, Yoshie Iizaki, Nobuo Maseki, Machiko Kawamura, Kazuhiko Kobayashi, Daisuke Takei, Tomoya Abe, Makoto Hanai, Toshiaki Nakayama, Yu Nishimura, Yasumasa Shimano, Kengo Takeuchi, Reimi Asaka, Satoko Baba","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The patient was a 51-year-old man who was diagnosed as having prostate cancer(adenocarcinoma)in December Year X-3. He underwent total prostatectomy in June Year X-2. The lesions were confined to the right lobe of the prostate. Examinations revealed no evidence of metastasis. At the same time, he developed bicytopenia, with a serum soluble interleukin-2 receptor(sIL-2R)level of 4,137 U/mL(220-530). Examination of a naturally dried peripheral blood smear revealed one cell that resembled a hairy cell. Genetic analysis of a blood specimen revealed no BRAF exon 15 mutation(V600E). Bone marrow examination showed no abnormalities. Positron emission tomography/computed tomography(PET/CT)revealed mild accumulation at multiple sites, but localized to the vertebrae. Magnetic resonance imaging(MRI)showed abnormal signals in the vertebrae. We performed vertebral biopsy of Th12, and histopathological examination revealed the diagnosis of hairy cell leukemia(HCL). Genetic analysis of the biopsy specimen also revealed a BRAF exon15(V600E)mutation. Since he had no clinical symptoms, he was carefully followed up without treatment. In April Year X, he still remained asymptomatic, and his blood counts had improved spontaneously. However, a repeat PET/CT revealed increased accumulation in the spine. Bone lesions due to bone invasion of HCL are mainly caused by bone resorption, and TNF-α is considered to be closely involved in the development of the osteolytic lesions. The finding of these bone lesions suggested that he was at risk for the development of compression fractures.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"52 2","pages":"135-140"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143617393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A Case of Bullous Pemphigoid after Combined Chemotherapy of Durvalumab, Gemcitabine and Cisplatin for Intrahepatic Cholangiocarcinoma]. 【杜伐单抗、吉西他滨、顺铂联合化疗治疗肝内胆管癌后出现大疱性类天疱疮1例】。
Tomoki Hata, Akinobu Yasuyama, Takeo Hara, Miho Okano, Osamu Takayama, Yongkook Kim, Junichi Hasegawa, Haruhiko Imamoto
{"title":"[A Case of Bullous Pemphigoid after Combined Chemotherapy of Durvalumab, Gemcitabine and Cisplatin for Intrahepatic Cholangiocarcinoma].","authors":"Tomoki Hata, Akinobu Yasuyama, Takeo Hara, Miho Okano, Osamu Takayama, Yongkook Kim, Junichi Hasegawa, Haruhiko Imamoto","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The patient is a 66-year-old man. He underwent a total of 9 courses of GCD therapy(gemcitabine+cisplatin+durvalumab)for intrahepatic cholangiocarcinoma with direct invasion of the greater omentum and abdominal wall and surrounding peritoneal dissemination. The tumor had shrunk and was judged to be curative, and laparoscopic hepatic S4a/S5 subsegmentectomy and S6 partial hepatectomy were performed at 8 months after the initial diagnosis. On the 24th postoperative day, pruritic petechial erythema appeared on the abdomen and lower extremities, some of which were accompanied by blisters. The patient tested positive for anti-BP180 antibody and was diagnosed as bullous pemphigoid. The skin rash improved after systemic steroid administration, and the patient is currently under observation. Bullous pemphigoid is a rare immune-related adverse event, but careful observation of skin symptoms is necessary for early detection.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"52 2","pages":"170-172"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143617346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A Case of Pancreatic Carcinoma and Short Bowel Syndrome with Long-Term Survival]. [胰腺癌合并短肠综合征1例,长期存活]。
Yasuji Hashimoto, Yuta Kobayashi, Yasuaki Miyazaki, Toshiya Michiura, Kazuo Yamabe
{"title":"[A Case of Pancreatic Carcinoma and Short Bowel Syndrome with Long-Term Survival].","authors":"Yasuji Hashimoto, Yuta Kobayashi, Yasuaki Miyazaki, Toshiya Michiura, Kazuo Yamabe","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A 75-year-old woman was admitted to our hospital with a complaint of jaundice and elevated liver enzyme levels. She was diagnosed with pancreatic head carcinoma after examination. She had undergone massive resection of the small intestine due to thrombosis of the superior mesenteric artery at 48 years of age, and the remaining ileum was approximately 70 cm in length. As the patient had no symptoms of short bowel syndrome, we deemed surgery to be feasible. We performed a subtotal stomach-preserving pancreaticoduodenectomy with gastropancreatic anastomosis to preserve the longest possible effective small intestine length. Although surgical site infection was observed postoperatively, parenteral nutrition was discontinued on the 24th postoperative day, and the patient was discharged on the 54th postoperative day. The final diagnosis was pancreatic head carcinoma, pT3N0M0, pStage ⅡA. At 54 months postoperatively, the patient is alive, has no recurrence, and is in a good nutritional condition. Although patients are prone to nutritional disorders after massive resection of the small intestine or pancreaticoduodenectomy, the nutritional status should be maintained using a surgical technique that can leave a long effective residual small intestine length.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"52 2","pages":"179-181"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143617427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A Case of Laparoscopic Liver and Colon Resection for Recurrent Hepatocellular Carcinoma and Metachronous Colon Metastasis of Hepatocellular Carcinoma]. [腹腔镜肝结肠切除术治疗复发性肝癌及肝癌异时性结肠转移一例]。
Yoshiki Kurihara, Shuhei Yamada, Tsutomu Sato, Nanase Kawamura, Lucia Takahashi, Yoriki Matsuda, Haruka Motegi, Kai Chen, Tomonori Shimbo, Toshiki Wakabayashi, Isao Kikuchi, Masato Sageshima, Michinobu Umakoshi
{"title":"[A Case of Laparoscopic Liver and Colon Resection for Recurrent Hepatocellular Carcinoma and Metachronous Colon Metastasis of Hepatocellular Carcinoma].","authors":"Yoshiki Kurihara, Shuhei Yamada, Tsutomu Sato, Nanase Kawamura, Lucia Takahashi, Yoriki Matsuda, Haruka Motegi, Kai Chen, Tomonori Shimbo, Toshiki Wakabayashi, Isao Kikuchi, Masato Sageshima, Michinobu Umakoshi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>An 81-year-old man underwent a partial laparoscopic hepatectomy for tumors in the S7 segment of the liver and was diagnosed with moderately to poorly differentiated hepatocellular carcinoma(HCC). Two years and 10 months later, MRI identified a 10 mm tumor in the S8 segment of the liver, indicative of highly differentiated HCC. Colorectal endoscopy subsequently revealed a submucosal tumor in the transverse colon, with biopsy findings showing features similar to the previous HCC. Immunohistochemistry results showed CDX2-negative, CK20-negative, and hepatocyte paraffin 1(Hep Par 1)-positive markers, confirming a diagnosis of metachronous colorectal metastasis of HCC. The patient underwent laparoscopic partial hepatectomy of the S8 segment and right hemicolectomy. Histopathological evaluation identified the liver tumor tissue as highly differentiated HCC, suggestive of metachronous multicentric recurrence. In contrast, the colonic tumor was characterized as moderately to poorly differentiated HCC, resembling the initial HCC. As there was no serosal exposure or lymph node metastasis, metachronous hematogenous recurrence of HCC in the colon was observed.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"52 2","pages":"129-133"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143617421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The Short-Term Outcome of Robotic Liver Resection-A Single Institutional Experience]. [机器人肝脏切除术的短期结果-单一机构经验]。
Yutaka Takeda, Yoshiaki Ohmura, Go Shinke, Mitsuru Kinoshita, Yoshifumi Iwagami, Yoshiro Yukawa, Asami Arita, Kiminori Yanagisawa, Shinsuke Katsuyama, Ryo Ikeshima, Masayuki Hiraki, Keijiro Sugimura, Toru Masuzawa, Taishi Hata, Kohei Murata
{"title":"[The Short-Term Outcome of Robotic Liver Resection-A Single Institutional Experience].","authors":"Yutaka Takeda, Yoshiaki Ohmura, Go Shinke, Mitsuru Kinoshita, Yoshifumi Iwagami, Yoshiro Yukawa, Asami Arita, Kiminori Yanagisawa, Shinsuke Katsuyama, Ryo Ikeshima, Masayuki Hiraki, Keijiro Sugimura, Toru Masuzawa, Taishi Hata, Kohei Murata","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Robotic liver resection(RLR)has been covered by insurance since 2022. We report our short-term outcomes of RLR performed in Kansai Rosai Hospital.</p><p><strong>Patients and method: </strong>Between May 2022 and November 2023, 35 patients underwent RLR. Control 789 patients who received laparoscopic liver resection(LLR)between January 2010 and November 2023 were included for comparison.</p><p><strong>Results: </strong>No significant differences were noted between non-anatomical RLR and anatomical RLR groups with respect to blood loss, Pringle rate, conversion rate, biliary fistula and hospital stay, respectively. Difficulty score was higher(4.07 vs 7.71 p<0.0001)and console time was longer(212 vs 331 min p=0.0035)in anatomical RLR group than non-anatomical RLR group. No significant differences were noted between RLR and LLR groups with respect to patient age, gender, Child-Pugh, liver damage and diagnosis, respectively. Anatomical LR rate was higher(18/17 vs 534/255, 48.6 vs 32.3%, p=0.0454)and open conversion rate was lower(0 vs 0.5%, p=0.0296)in RLR group than LLR group. No significant differences were noted between RLR and LLR groups with respect to blood loss, postoperative mortality, morbidity and hospital stay, respectively.</p><p><strong>Conclusion: </strong>Although further studies are still needed to confirm the benefit of RLR, RLR is safe, minimally invasive, and effective approach to the management of liver tumor.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"52 2","pages":"152-154"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143617391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Short-Term Outcomes of Robot-Assisted Laparoscopic Surgery for Rectal Cancer in Our Department]. [我科机器人辅助腹腔镜直肠癌手术的近期疗效]。
Hajime Yokomizo, Sachiyo Okayama, Shunsuke Iwamoto, Shinichi Asaka, Takebumi Usui, Takeshi Shimakawa, Shunichi Shiozawa
{"title":"[Short-Term Outcomes of Robot-Assisted Laparoscopic Surgery for Rectal Cancer in Our Department].","authors":"Hajime Yokomizo, Sachiyo Okayama, Shunsuke Iwamoto, Shinichi Asaka, Takebumi Usui, Takeshi Shimakawa, Shunichi Shiozawa","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We investigated the short-term outcomes of robot-assisted surgery for rectal cancer in our department. Among 98 cases of colorectal cancer who underwent robot-assisted surgery between October 2019 and December 2023, 91 cases of rectal cancer surgery using the da Vinci X surgical system® were included, and clinicopathological and surgical outcomes were examined. The patients included 58 males and 33 females, with a median age of 71 years. The surgical procedures were high anterior resection in 9 cases, low anterior resection in 39 cases, ultra-low anterior resection in 14 cases, inter-sphincter resection in 3 cases, Hartmann's procedure in 6 cases, and rectal amputation in 20 cases. Lateral lymph node dissection was performed in 6 cases, and diverting ileostomy was performed in 20 cases. The surgical outcomes were the median operative time 363 minutes, console time 196 minutes, and blood loss 20 mL. Complications of Clavien-Dindo classification Ⅲ or higher were observed in 18.7% of cases, and the postoperative hospital stay was 16 days. In our department, we basically perform robot-assisted surgery for rectal cancer cases, except for some RS cases, but there are not a few postoperative complications, and we think that it is necessary to analyze the causes of these in the future.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"52 2","pages":"149-151"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143617390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Actual Assignment of Patient Attendants for Home-Based Red Blood Cell Transfusion Therapy]. 【家庭红细胞输血治疗中护理人员的实际分配】。
Mayumi Yamada, Yutaro Kamiyama, Kota Ohashi
{"title":"[Actual Assignment of Patient Attendants for Home-Based Red Blood Cell Transfusion Therapy].","authors":"Mayumi Yamada, Yutaro Kamiyama, Kota Ohashi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to investigate the assignment of\" patient attendants\"as outlined in the guidelines for home-based red blood cell transfusion therapy in Japan.</p><p><strong>Methods: </strong>Among patients with cancer who received home-based treatment at our institution during the study period, 93 patients who underwent home-based red blood cell transfusion therapy and either died or were diagnosed in their terminal stage were included. Data were collected from medical records and analyzed retrospectively.</p><p><strong>Results: </strong>All red blood cell transfusions were performed by medical staff at home or in residential care facilities. Family members were assigned as patient attendants for home care patients who had family members living with them. However, no attendants were assigned to home care patients living alone. For institutionalized patients, facility staff served as patient attendants. No serious adverse events occurred.</p><p><strong>Discussion: </strong>While having patient attendants is essential for ensuring safe home-based blood transfusions, our findings suggest that the assignment of attendants depends on the patient's living situation. With an expected increase in transfusion-dependent patients who wish to receive home-based transfusions, it is crucial to develop a system that supports safe and appropriate transfusions, regardless of the patient's living environment.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"52 2","pages":"125-128"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143617436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信